Shenzhen Salubris Pharmaceuticals Co Ltd (002294) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥400.70 Million ≈ $58.63 Million USD) by net assets (CN¥8.93 Billion ≈ $1.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002294 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Shenzhen Salubris Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shenzhen Salubris Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Salubris Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Salubris Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Firefly Aerospace Inc. Common Stock
NASDAQ:FLY
-0.057x
Trina Solar Co Ltd
SHG:688599
0.040x
Shenzhen Zhongjin Lingnan Nonfemet Co Ltd
SHE:000060
0.005x
Scout24 AG
XETRA:G24
0.101x
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
0.022x
Ameris Bancorp
NASDAQ:ABCB
0.026x
Kunshan Kinglai Hygienic Materials Co Ltd
SHE:300260
0.016x
Turkcell Iletisim Hizmetleri AS
NYSE:TKC
0.003x

Annual Cash Flow Conversion Efficiency for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shenzhen Salubris Pharmaceuticals Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.75 Billion
≈ $1.28 Billion
CN¥1.19 Billion
≈ $173.59 Million
0.136x +25.52%
2023-12-31 CN¥8.06 Billion
≈ $1.18 Billion
CN¥869.79 Million
≈ $127.28 Million
0.108x -11.28%
2022-12-31 CN¥7.98 Billion
≈ $1.17 Billion
CN¥970.80 Million
≈ $142.06 Million
0.122x -17.36%
2021-12-31 CN¥8.05 Billion
≈ $1.18 Billion
CN¥1.18 Billion
≈ $173.40 Million
0.147x -40.08%
2020-12-31 CN¥5.59 Billion
≈ $818.24 Million
CN¥1.37 Billion
≈ $201.11 Million
0.246x +8.75%
2019-12-31 CN¥6.67 Billion
≈ $975.50 Million
CN¥1.51 Billion
≈ $220.47 Million
0.226x +15.83%
2018-12-31 CN¥6.87 Billion
≈ $1.01 Billion
CN¥1.34 Billion
≈ $196.18 Million
0.195x -17.57%
2017-12-31 CN¥6.16 Billion
≈ $901.18 Million
CN¥1.46 Billion
≈ $213.31 Million
0.237x -9.93%
2016-12-31 CN¥5.46 Billion
≈ $798.98 Million
CN¥1.43 Billion
≈ $209.96 Million
0.263x +16.85%
2015-12-31 CN¥4.70 Billion
≈ $687.12 Million
CN¥1.06 Billion
≈ $154.53 Million
0.225x -13.27%
2014-12-31 CN¥3.79 Billion
≈ $554.32 Million
CN¥982.25 Million
≈ $143.73 Million
0.259x +21.59%
2013-12-31 CN¥3.13 Billion
≈ $458.73 Million
CN¥668.52 Million
≈ $97.83 Million
0.213x +6.65%
2012-12-31 CN¥2.61 Billion
≈ $381.44 Million
CN¥521.21 Million
≈ $76.27 Million
0.200x +56.74%
2011-12-31 CN¥2.13 Billion
≈ $312.36 Million
CN¥272.32 Million
≈ $39.85 Million
0.128x +27.50%
2010-12-31 CN¥1.87 Billion
≈ $272.96 Million
CN¥186.65 Million
≈ $27.31 Million
0.100x +20.96%
2009-12-31 CN¥1.62 Billion
≈ $237.55 Million
CN¥134.28 Million
≈ $19.65 Million
0.083x -72.08%
2008-12-31 CN¥262.90 Million
≈ $38.47 Million
CN¥77.89 Million
≈ $11.40 Million
0.296x -18.02%
2007-12-31 CN¥145.96 Million
≈ $21.36 Million
CN¥52.75 Million
≈ $7.72 Million
0.361x +220.57%
2006-12-31 CN¥106.48 Million
≈ $15.58 Million
CN¥12.00 Million
≈ $1.76 Million
0.113x --

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.96 Billion
CN¥33.87 Billion CNY
Market Cap Rank
#3642 Global
#541 in China
Share Price
CN¥30.38
Change (1 day)
+0.73%
52-Week Range
CN¥30.16 - CN¥68.30
All Time High
CN¥68.30
About

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also develops Sacubit… Read more